European Heart Failure Mission
Driving political urgency in heart failure across the EU.
Find out more
Innovation: early diagnosis in community settings
This report focuses on early diagnosis of heart failure in community settings, identifying four key areas of innovation.
Find out more
Trailblazers Hub
The Heart Failure Policy Network is gathering inspirational examples of system transformation and political advocacy in heart failure
Find out more
heart graphic

Helping advance meaningful policy change on heart failure

The Heart Failure Policy Network is an independent, multidisciplinary platform of healthcare professionals, advocacy groups and policymakers from across Europe.

We aim to raise awareness of the unmet needs surrounding heart failure and its care, and to help drive meaningful changes in policy and practice.

Find out more
Latest
Event urges inclusion of heart failure in a European Cardiovascular Health Plan
23 October 2024

The Hungarian Society of Cardiology Working Group on Heart Failure and Myocardial Diseases, with support from the HFPN, hosted an event to launch a policy submission on opportunities to reduce the burden of heart failure in Europe.

Read article
Meet our members: Teresa Castiello
11 October 2024

We speak to HFPN member Dr Teresa Castiello, who is a consultant cardiologist at the Homerton Hospital NHS Foundation Trust in the UK.

Read article
Meet our members: Cristina Enjuanes
3 October 2024

We speak to HFPN member Cristina Enjuanes, Coordinator of the Community Heart Unit at the Hospital de Bellvitge, L’Hospitalet de Llobregat, Spain

Read article
heart failure graphic
What is heart failure?

Affecting at least 15 million adults in Europe, heart failure is a common but complex clinical syndrome that occurs when the heart is unable to pump enough blood to meet body’s needs.

Its prevalence is expected to rise due to population ageing and improved survival rates for other long-term conditions, including cardiovascular diseases.

Find out more
The Heart Failure Policy Network is an independent, multidisciplinary platform made possible with financial support from AstraZeneca and Roche Diagnostics. The content produced by the Network is not biased toward any specific treatment or therapy. All outputs are guided and endorsed by the Network’s members. All members provide their time for free. The Network is hosted by The Health Policy Partnership .